JP2010536797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010536797A5 JP2010536797A5 JP2010521229A JP2010521229A JP2010536797A5 JP 2010536797 A5 JP2010536797 A5 JP 2010536797A5 JP 2010521229 A JP2010521229 A JP 2010521229A JP 2010521229 A JP2010521229 A JP 2010521229A JP 2010536797 A5 JP2010536797 A5 JP 2010536797A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- rapamycin
- ethanol
- human subject
- macular degeneration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96528207P | 2007-08-16 | 2007-08-16 | |
| US96525807P | 2007-08-16 | 2007-08-16 | |
| PCT/US2008/073520 WO2009023877A2 (en) | 2007-08-16 | 2008-08-18 | Formulations for treatment of ocular diseases or conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010536797A JP2010536797A (ja) | 2010-12-02 |
| JP2010536797A5 true JP2010536797A5 (enExample) | 2013-07-25 |
Family
ID=40351498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010521229A Pending JP2010536797A (ja) | 2007-08-16 | 2008-08-18 | 眼の疾患または状態を治療するための製剤 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2187743B1 (enExample) |
| JP (1) | JP2010536797A (enExample) |
| KR (1) | KR20100055482A (enExample) |
| CN (1) | CN101827523A (enExample) |
| ES (1) | ES2507078T3 (enExample) |
| WO (1) | WO2009023877A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006130775A2 (en) | 2005-06-01 | 2006-12-07 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| CA2635280C (en) | 2006-02-22 | 2017-12-12 | Edison Pharmaceuticals, Inc. | Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| US20100273894A1 (en) | 2009-04-28 | 2010-10-28 | Miller Guy M | Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones |
| ES2758554T3 (es) | 2009-12-08 | 2020-05-05 | Univ Case Western Reserve | Aminoácidos gama para tratamiento de trastornos oculares |
| WO2013056233A1 (en) * | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Treatment of ocular disease |
| US8912215B2 (en) | 2011-12-13 | 2014-12-16 | Everon Biosciences, Inc. | Rapamycin composition |
| CN103239399B (zh) * | 2013-05-30 | 2016-06-29 | 山东兴瑞生物科技有限公司 | 一种西罗莫司纳米混悬剂及其制备方法 |
| KR101674457B1 (ko) * | 2013-11-04 | 2016-11-09 | 아주대학교산학협력단 | 다사티닙 또는 이의 약학적으로 허용되는 염을 유효성분으로 포함하는 혈관 투과성 관련 질환의 예방 또는 치료용 약학적 조성물 |
| KR102638112B1 (ko) * | 2015-02-02 | 2024-02-20 | 산텐 세이야꾸 가부시키가이샤 | 폴리아프론 및 이의 안검 투여 |
| EP3272362B1 (en) * | 2015-03-18 | 2023-12-13 | Santen Pharmaceutical Co., Ltd. | Sustained-release pharmaceutical composition |
| JP6541124B2 (ja) * | 2015-03-23 | 2019-07-10 | 国立大学法人大阪大学 | びまん性神経線維腫用の外用薬 |
| EP3342410A4 (en) * | 2015-08-28 | 2019-04-24 | Nippon Kayaku Kabushiki Kaisha | PHARMACEUTICAL COMPOSITION WITH RAPAMYCIN OR DERIVATIVES THEREOF |
| BR112018005305A2 (pt) * | 2015-09-18 | 2018-10-09 | Santen Pharmaceutical Co., Ltd. | agente profilático ou terapêutico da queratite fungal |
| KR102373289B1 (ko) | 2016-05-25 | 2022-03-10 | 산텐 세이야꾸 가부시키가이샤 | 지속성 부종을 갖는 삼출성 노인성 황반변성을 치료하기 위한 시롤리무스의 용도 |
| KR20190025635A (ko) * | 2016-06-30 | 2019-03-11 | 듀렉트 코퍼레이션 | 데포 제형 |
| JP2020514404A (ja) * | 2016-12-27 | 2020-05-21 | ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 眼内薬物送達デバイス及び関連方法 |
| IL302385B2 (en) * | 2017-01-06 | 2024-06-01 | Palvella Therapeutics Inc | Non-aqueous preparations of mTOR inhibitors and methods of use |
| EP3501496A1 (en) | 2017-12-22 | 2019-06-26 | Cosmo Technologies Ltd. | Liquid delivery composition |
| EP3813789A1 (en) | 2018-06-28 | 2021-05-05 | Arx, LLC | Dispensing method for producing dissolvable unit dose film constructs |
| JP2021530463A (ja) * | 2018-07-02 | 2021-11-11 | パルヴェラ セラピューティクス、インク． | ｍＴＯＲ阻害剤の無水組成物および使用方法 |
| CN109431997B (zh) * | 2018-12-20 | 2021-06-04 | 武汉科福新药有限责任公司 | 一种雷帕霉素局部注射制剂及其制备方法 |
| WO2021132565A1 (ja) * | 2019-12-26 | 2021-07-01 | 参天製薬株式会社 | シロリムスまたはその塩を含有する水性懸濁組成物 |
| CN112263670A (zh) * | 2020-10-22 | 2021-01-26 | 温州医科大学 | 硼替佐米及其制剂在制备治疗脉络膜新生血管性相关疾病药物上的应用及滴眼液制备方法 |
| US20240285724A1 (en) * | 2021-06-15 | 2024-08-29 | Onl Therapeutics, Inc. | Methods and compositions for treating ocular disorders and diseases |
| CN115337263B (zh) * | 2022-08-09 | 2023-10-03 | 江苏汉晨药业有限公司 | 一种盐酸洛美沙星滴眼液 |
| CN115813863A (zh) * | 2022-12-15 | 2023-03-21 | 广州因明生物医药科技股份有限公司 | 一种可自发团聚的微球及其制备方法 |
| CN119258216A (zh) * | 2023-07-05 | 2025-01-07 | 沈阳兴齐眼药股份有限公司 | 眼用药物组合物、其制备方法、含其的眼用药盒及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6599891B2 (en) * | 2001-07-20 | 2003-07-29 | Qlt Inc. | Treatment of macular edema |
| ES2428354T3 (es) * | 2002-09-18 | 2013-11-07 | Trustees Of The University Of Pennsylvania | Rapamicina para usar en la inhibición o prevención de la neovascularización coroidea |
| US20040091455A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US20060182783A1 (en) * | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Sustained release intraocular drug delivery systems |
| JP4974903B2 (ja) * | 2005-02-09 | 2012-07-11 | 参天製薬株式会社 | 疾患または状態を処置するための液体処方物 |
| US20060216288A1 (en) * | 2005-03-22 | 2006-09-28 | Amgen Inc | Combinations for the treatment of cancer |
-
2008
- 2008-08-18 EP EP08827362.8A patent/EP2187743B1/en not_active Not-in-force
- 2008-08-18 WO PCT/US2008/073520 patent/WO2009023877A2/en not_active Ceased
- 2008-08-18 ES ES08827362.8T patent/ES2507078T3/es active Active
- 2008-08-18 JP JP2010521229A patent/JP2010536797A/ja active Pending
- 2008-08-18 CN CN200880112404A patent/CN101827523A/zh active Pending
- 2008-08-18 KR KR1020107005823A patent/KR20100055482A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010536797A5 (enExample) | ||
| Casson | Medical therapy for glaucoma: A review | |
| Lanier et al. | Review of approaches for increasing ophthalmic bioavailability for eye drop formulations | |
| JP6629840B2 (ja) | 眼の疾患および障害を処置するための化合物 | |
| Janoria et al. | Novel approaches to retinal drug delivery | |
| Moisseiev et al. | Drug delivery to the posterior segment of the eye | |
| WO2010004594A1 (en) | Ophthalmic compositions for treating pathologies of the posterior segment of the eye | |
| WO2010125416A1 (en) | Drug delivery to the anterior and posterior segments of the eye | |
| US20090118262A1 (en) | Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery | |
| US9161923B2 (en) | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
| JP2015526467A5 (enExample) | ||
| TW201408287A (zh) | 用於預防及／或治療乾眼症之組成物、方法及／或裝置 | |
| KR102266014B1 (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| TW201705956A (zh) | 唑系抗真菌藥之對眼瞼皮膚的投與 | |
| Rupenthal et al. | progress in ocular drug delivery: challenges and constraints | |
| Kiernan et al. | Topical drug delivery for posterior segment disease | |
| MX2011005586A (es) | Composiciones de soluciones oculares topicas para suministrar concentraciones efectivas de agente activo al segmento posterior del ojo. | |
| CN103826631A (zh) | 用于治疗视网膜疾病的包含4-溴-n-(咪唑烷-2-亚基)-1h-苯并咪唑-5-胺的药物组合物 | |
| AU2019208350A1 (en) | Suspension compositions of multi-target inhibitors | |
| JP7417531B2 (ja) | 選択的ｓｙｋ阻害剤の使用方法および医薬組成物 | |
| HK40092417A (zh) | 用於治疗眼科疾病和障碍的化合物 |